SCHEMBL439647

SCHEMBL439647

Cc1ccn(C)c(=O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15360079 0.76 SMPD3 (0.44)
SCHEMBL15034720 0.76 MAPT (0.54)
SCHEMBL27952255 0.74 PIK3CB (0.41)
SCHEMBL31227892 0.74
SCHEMBL20611026 0.74
SCHEMBL25428969 0.74
SCHEMBL23128404 0.74
SCHEMBL11250319 0.74
SCHEMBL12884843 0.74 KDM4E (0.34)
SCHEMBL24400469 0.74 KDM4E (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873319-B2 Cyclic di-nucleotide induction of type I interferon THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-01-16 US disclosed
US-20230416934-A1 ACID-FREE PYROLYTIC SYNTHESIS OF M-N-C CATALYST THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-12-28 US disclosed
US-20230227474-A1 COMPOSITIONS AND METHODS FOR CORRECTION OF ABERRANT SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2023-07-20 US disclosed
US-20230159491-A1 Antimicrobial Compounds and Methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 US disclosed
US-20230054781-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-02-23 US disclosed
US-20230009712-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-01-12 US disclosed
EP-4116310-A1 METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS FUJIFILM Wako Pure Chemical Corporation (JP) 2023-01-11 EP disclosed
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2022-02-17 US disclosed
EP-3707151-B1 STING MODULATOR COMPOUNDS, AND METHODS OF MAKING AND USING TAKEDA PHARMACEUTICALS CO (JP) 2022-01-05 EP disclosed
EP-3912984-A1 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV Janssen BioPharma, Inc. (US) 2021-11-24 EP disclosed
US-20080227676-A1 Amine reaction compounds comprising one or more active ingredient PROCTER & GAMBLE COMPANY, THE 2008-09-18 US disclosed
US-20070232507-A1 Amine reaction compounds comprising one or more active ingredient THE PROCTER & GAMBLE COMPANY ATTENTION: CHIEF PATENT COUNSEL (US) 2007-10-04 US disclosed
US-20070099818-A1 Amine reaction compounds comprising one or more active ingredient THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US disclosed
US-7186700-B2 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies IDENIX PHARMACEUTICALS, INC. (US) 2007-03-06 US disclosed
CN-1288157-C Dioxinopyridine compounds for the treatment of impaired fundic relaxation, process for their preparation and their use JANSSEN PHARMACEUTICA NV (BE) 2006-12-06 CN disclosed
CN-1781921-A Compounds for treating impaired fundic relaxation JANSSEN PHARMACEUTICA NV (BE) 2006-06-07 CN disclosed
CN-1437602-A Compounds for treating impaired fundic relaxation JANSSEN PHARMACEUTICA NV (BE) 2003-08-20 CN disclosed
CN-1092420-A Compound GLAXO GROUP LTD (GB) 1994-09-21 CN disclosed
CN-86108620-A Pyridine derivate and manufacture method thereof contain the preparation of these compounds and as the application of agricultural chemicals 1987-08-05 CN disclosed
US-4395406-A 5-Halopyrimid-2-ones NYEGAARD & CO. A/S (NO) 1983-07-26 US disclosed